Results 171 to 180 of about 3,035 (216)
Targeted deep sequencing identifies mosaicism in patients with immune dysregulation. [PDF]
J Allergy Clin ImmunolSchmitz EG, Paul AJ, Ghosh R, Saucier N, Kolicheski A, Risma SI, McDaniels KP, Liu M, Lewis KL, de Jesus AA, Alehashemi S, Fronick CC, Stein D, Dominguez D, Hiraki LT, Lee JH, Norman S, Peng CR, Ward BR, Pettiford LH, Platt A, Lawrence MG, Rocco JM, Al-Herz W, Zerbe CS, Atkinson TP, Peng XP, Allenspach EJ, Hoytema van Konijnenburg DP, Platt CD, Elkins M, Walter JE, Bleesing JJ, Klion A, Ramaswami R, Uzel G, Lionakis MS, Dissanayake D, Su HC, Cortese I, Fuss IJ, Bergerson JRE, Dropulic L, Sereti I, Lisco A, Itan Y, Milner JD, Bogunovic D, Goldbach-Mansky R, Rao VK, Delmonte OM, Notarangelo LD, Keller MD, Durkee-Shock J, Cohen JI, Similuk MN, Holland SM, Griffith M, Griffith OL, Vogel TP, Canna S, Freeman AF, Walkiewicz MA, Cooper MA. +63 moreeuropepmc +1 more sourceIdentification of an Induced Orthosteric Pocket in IL-23: A New Avenue for Non-biological Therapeutic Targeting. [PDF]
ACS Chem BiolLecomte FC, Joseph JS, Stalewski J, Shen Q, Arnoult E, Sridhar V, Liu M, Hu Y, Gasendo JG, Ben Arie H, Keinan N, Keidar L, Aviv I, Ruvinov E, Grandjean J, Dores-Silva PR, Mak A, Santoso B, Kim S, Shende V, Wever WJ, Mirzadegan T, Zhu Z, Fuchs B, Pinton P, Szabady R. +25 moreeuropepmc +1 more sourceEvaluating a whole-school approach to addressing gender-based violence in Scottish secondary schools (Equally Safe at School): a study protocol for a type I hybrid effectiveness-implementation trial. [PDF]
BMJ OpenHamilton C, Lewis R, Blake C, Purvis A, Vaczy C, Deidda M, Kerr N, Waiting L, Dawson K, Willis M, McIntosh E, Taylor RS, Moore L, Mitchell KR. +13 moreeuropepmc +1 more source